Obesity has frequently been dubbed an epidemic in the United States and is credited with causing or contributing to a wide variety of other chronic ailments, including cardiovascular disease and osteoarthritis. However, it’s also a frequent comorbidity for another common set of connected conditions — psoriasis and psoriatic arthritis.
Despite its frequent occurrence, questions still exist about the role obesity plays in contributing to psoriatic disease and its severity. There’s also been growing discussion around whether weight loss and management can be an effective therapeutic avenue.
At a minimum, many industry experts agree addressing obesity can be a vital arrow in the quiver for treating psoriatic disease.
“Obesity is a very common comorbidity of psoriasis and psoriatic arthritis,” says Mark Lebwohl, M.D., dermatology professor at Icahn School of Medicine at Mount Sinai. “It has a negative impact on the response to therapies so that many therapies don’t work as well.”
In fact, he says, existing research and clinical care interventions have shown patients who lose weight do respond better to psoriasis treatment.